{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:25:13Z","timestamp":1792218313932,"version":"4.4.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,22]]},"abstract":"<jats:p>\n                    Neoadjuvant treatment (NAT) has been increasingly used for locally advanced gastric cancer considering the potential for systemic dissemination and inoperability of the disease. This study aimed to evaluate the effects of NAT on the early postoperative complications and pathological outcomes in patients undergoing surgery for gastric cancer. We included patients with gastric cancer who underwent surgery at a tertiary care center between January 2014 and December 2021. The patients were divided into NAT receiving (Group I) and non-receiving (Group II) groups. Demographic data, clinical characteristics, intraoperative and postoperative complications, and pathological findings were retrospectively analyzed and compared between the 2 groups. Among the 186 patients, 27% (n\u2005=\u200551) were in group I and 73% (n\u2005=\u2005135) were in group II. The 2 groups were comparable in terms of their demographic characteristics. There were no significant differences in surgery time (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.932), intraoperative complication rates (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.993), postoperative complications (Clavien\u2013Dindo grade\u2005\u2265\u2005III) (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.549), or anastomotic leakage rates (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05) between the groups. Both groups had a similar median number of total harvested lymph nodes (n\u2005=\u200528,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.917), metastatic lymph nodes (n\u2005=\u20056,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.509), and R0 resection rates (94% vs 95, 6%\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.707). Subgroup analysis revealed no significant difference in early postoperative complication rates between patients receiving chemotherapy and chemoradiotherapy (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.330). Neoadjuvant treatment did not appear to increase the risk of early postoperative complications or affect the extent of lymphadenectomy in patients who underwent curative surgery for gastric cancer. These findings support the surgical safety and feasibility of NAT, particularly in multidisciplinary settings. A longer follow-up is required to assess the impact on survival outcomes and long-term complications.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043934","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T21:03:00Z","timestamp":1756846980000},"page":"e43934","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The impact of neoadjuvant treatment on early postoperative complications and pathological outcomes in gastric cancer patients: A retrospective cohort study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2973-429X","authenticated-orcid":false,"given":"Irem","family":"Karatas","sequence":"first","affiliation":[{"name":"Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2956-4486","authenticated-orcid":false,"given":"Cemil Burak","family":"Kulle","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0463-6335","authenticated-orcid":false,"given":"Adem","family":"Bayraktar","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-0503","authenticated-orcid":false,"given":"Ilker","family":"Ozgur","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0949-7944","authenticated-orcid":false,"given":"Neslihan","family":"Berker","sequence":"additional","affiliation":[{"name":"Department of Pathology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-2137","authenticated-orcid":false,"given":"Melek","family":"Buyuk","sequence":"additional","affiliation":[{"name":"Department of Pathology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3311-3581","authenticated-orcid":false,"given":"Mehmet Turker","family":"Bulut","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5390-2185","authenticated-orcid":false,"given":"Metin","family":"Keskin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260430","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R3-20260430","first-page":"1","article-title":"Japanese gastric cancer treatment guidelines 2018 (5th edition).","volume":"24","year":"2021","journal-title":"Gastric Cancer"},{"key":"R4-20260430","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022.","volume":"20","author":"Ajani","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"R5-20260430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42047-024-00162-4","article-title":"Advancements and challenges in gastric cancer: epidemiology, biomarkers, and therapeutic strategies.","volume":"7","author":"Nishimuni","year":"2024","journal-title":"Surg Exp Pathol"},{"key":"R6-20260430","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12885-025-13474-9","article-title":"A conceptual model for advanced\/metastatic gastric or gastroesophageal junction cancer: a review of qualitative studies and results from patient interviews.","volume":"25","author":"Sowell","year":"2025","journal-title":"BMC Cancer"},{"key":"R7-20260430","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1586\/17474124.2015.1094373","article-title":"Updated evidence on adjuvant treatments for gastric cancer.","volume":"9","author":"Kanda","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R8-20260430","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"R9-20260430","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer.","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"R10-20260430","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann Oncol"},{"key":"R11-20260430","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10120-017-0781-y","article-title":"Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications.","volume":"21","author":"Eto","year":"2018","journal-title":"Gastric Cancer"},{"key":"R12-20260430","first-page":"103411","article-title":"Revisiting the 8th AJCC system for gastric cancer: a review on validations, nomograms, lymph nodes impact, and proposed modifications.","volume":"75","author":"Mranda","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"R13-20260430","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1177\/147323001103900604","article-title":"Reduced lymph node harvest after neoadjuvant chemotherapy in gastric cancer.","volume":"39","author":"Wu","year":"2011","journal-title":"J Int Med Res"},{"key":"R14-20260430","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1245\/s10434-021-10803-7","article-title":"Lymph node evaluation after neoadjuvant chemotherapy for patients with gastric cancer.","volume":"29","author":"Shannon","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R15-20260430","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1245\/s10434-023-14813-5","article-title":"Postoperative complications after neoadjuvant chemotherapy versus upfront surgery in gastric adenocarcinoma: a population-based nationwide study in Finland.","volume":"31","author":"Putila","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"R16-20260430","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/CM9.0000000000001603","article-title":"Comparison of neoadjuvant chemotherapy followed by surgery vs. surgery alone for locally advanced gastric cancer: a meta-analysis.","volume":"134","author":"Yu","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"R17-20260430","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","article-title":"Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2\/3 trial.","volume":"17","author":"Al-Batran","year":"2016","journal-title":"Lancet Oncol"},{"key":"R18-20260430","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1245\/s10434-013-3384-9","article-title":"Prognostic significance of complications after curative surgery for gastric cancer.","volume":"21","author":"Kubota","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R19-20260430","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s11605-017-3496-9","article-title":"The effect of neoadjuvant chemoradiation on anastomotic leak and additional 30-day morbidity and mortality in patients undergoing total gastrectomy for gastric cancer.","volume":"21","author":"Haskins","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"R20-20260430","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejso.2016.11.022","article-title":"Development of a nomogram for predicting the risk of anastomotic leakage after a gastrectomy for gastric cancer.","volume":"43","author":"Tu","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"R21-20260430","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1245\/s10434-017-5827-1","article-title":"Preoperative chemoradiotherapy versus perioperative chemotherapy for patients with resectable esophageal or gastroesophageal junction adenocarcinoma.","volume":"24","author":"Anderegg","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R22-20260430","doi-asserted-by":"crossref","first-page":"1177557","DOI":"10.3389\/fonc.2023.1177557","article-title":"Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis.","volume":"13","author":"Zhu","year":"2023","journal-title":"Front Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:02:20Z","timestamp":1777590140000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":21,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043934","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}